Abstract:Backgrounds: During the Coronavirus Disease 2019 (COVID-19) epidemic, the massive spread of the disease has placed an enormous burden on the world's healthcare and economy. The early risk assessment system based on a variety of machine learning (ML) algorithms may be able to provide more accurate advice on the classification of COVID-19 patients, offering predictive, preventive, and personalized medicine (PPPM) solutions in the future. Methods: In this retrospective study, we divided a portion of the data into training and validation cohorts in a 7:3 ratio and established a model based on a combination of two ML algorithms first. Then, we used another portion of the data as an independent testing cohort to determine the most accurate and stable model and compared it with other scoring systems. Finally, patients were categorized according to risk scores and then the correlation between their clinical data and risk scores was studied. Results: The elderly accounted for the majority of hospitalized patients with COVID-19. The C-index of the model constructed by combining the stepcox[both] and survivalSVM algorithms was 0.840 in the training cohort and 0.815 in the validation cohort, which was calculated to have the highest C-index in the testing cohort compared to the other 119 ML model combinations. Compared with current scoring systems, including the CURB-65 and several reported prognosis models previously, our model had the highest AUC value of 0.778, representing an even higher predictive performance. In addition, the model's AUC values for specific time intervals, including days 7,14 and 28, demonstrate excellent predictive performance. Most importantly, we stratified patients according to the model's risk score and demonstrated a difference in survival status between the high-risk, median-risk, and low-risk groups, which means a new and stable risk assessment system was built. Finally, we found that COVID-19 patients with a history of cerebral infarction had a significantly higher risk of death. Conclusion: This novel risk assessment system is highly accurate in predicting the prognosis of patients with COVID-19, especially elderly patients with COVID-19, and can be well applied within the PPPM framework. Our ML model facilitates stratified patient management, meanwhile promoting the optimal use of healthcare resources.

Collective and Individual Assessment of the Risk of Death from COVID-19 for the Elderly, 2020-2022.

Development and Validation of a Scoring System to Predict the Mortality of Hospitalized Patients with SARS-CoV-2 Omicron: a Nationwide, Multicentre Study

Risk Assessment and Prediction of Severe or Critical COVID-19 Illness in Older Adults

Risk Factors for Mortality of Coronavirus Disease 2019 (COVID-19) Patients During the Early Outbreak of COVID-19: a Systematic Review and Meta-Analysis

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Risk factors for mortality in patients over 70 years old with COVID-19 in Wuhan at the early break: retrospective case series

COVID‐19 mortality and its predictors in the elderly: A systematic review

Real-time Prediction of COVID-19 related Mortality using Electronic Health Records

Demystifying COVID-19 mortality causes with interpretable data mining

Influencing Factors of Understanding COVID-19 Risks and Coping Behaviors among the Elderly Population

Systematic review on attitudes towards death and dying in adults 50 years and older living in countries with community transmission of COVID-19

Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study

Using Markov Chain Monte Carlo methods to estimate the age-specific case fatality rate of COVID-19

Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19

Clinical characteristics and prognostic factors in elderly patients with COVID-19

Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis

Development and validation of a predicted nomogram for mortality of COVID-19: a multicenter retrospective cohort study of 4,711 cases in multiethnic

Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study

A biomarker-based age, biomarkers, clinical history, sex (ABCS)-mortality risk score for patients with coronavirus disease 2019

Association Between Ageing Population, Median Age, Life Expectancy and Mortality in Coronavirus Disease (COVID-19)

Age-dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China